Intrapartum Maternal Glucose Control and Effect on Neonatal Hypoglycemia
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study is to assess whether a liberal intrapartum glycemic target range compared to usual care standard control ranges will lead to a decrease in the rate of neonatal hypoglycemia among pregnant patients in labor with diabetes.
Eligibility
Participation Requirements
Sex: Female
Healthy Volunteers: f
View:
• Pregnant patients with Pre-gestational (Type 1 or Type 2) or Gestational Diabetes
• Singleton Gestations
• Greater than or equal to 35 weeks gestation
• Planned for vaginal delivery at the University of Pittsburgh Medical Center Magee-Womens Hospital (UPMC MWH)
Locations
United States
Pennsylvania
Magee-Women's Hospital of UPMC
RECRUITING
Pittsburgh
Contact Information
Primary
Praveen Ramesh, M.D.
rameshp2@upmc.edu
412-641-4455
Backup
Maisa Feghali, M.D.
feghalim@mwri.magee.edu
412-641-4874
Time Frame
Start Date: 2024-12-03
Estimated Completion Date: 2026-06
Participants
Target number of participants: 218
Treatments
Active_comparator: Standard Intrapartum Glucose Target Range
The goal intrapartum glucose target range will be 70-110mg/dl. Insulin infusion will be initiated when maternal capillary glucose exceeds 110 mg/dL.
Experimental: Liberalized Intrapartum Glucose Target Range
The goal intrapartum glucose target range will be 70-160mg/dl. Insulin infusion will be initiated when maternal capillary glucose exceeds 160 mg/dL.
Related Therapeutic Areas
Sponsors
Leads: University of Pittsburgh